[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Observation
April 2016

Treatment of Eosinophilic Fasciitis With Sirolimus

Author Affiliations
  • 1Department of Dermatology, New York University School of Medicine, New York
  • 2Department of Dermatology, University of California, San Francisco
  • 3Department of Dermatology, Palo Alto Foundation Medical Group, Mountain View, California
JAMA Dermatol. 2016;152(4):488-490. doi:10.1001/jamadermatol.2016.0048

Eosinophilic fasciitis (EF) is a disorder in which the subcutaneous tissues become indurated and then sclerotic leading to myalgia, arthralgia, and occasionally contractures and disability. High-dose systemic steroids are first-line therapy; however, steroid-sparing agents are often used owing to disease progression or to avoid the adverse effects of long-term corticosteroid use. We describe a case of EF with rapid response to sirolimus.

A man in his 30s had a 6-month history of arthralgia involving his shoulders, hands, knees, ankles, and feet, which made it difficult for him to stand or walk for long periods. He complained of swelling and “skin tightness” of his arms, lower legs, and hands. On examination, he had woody induration of his distal extremities creating both peau d’orange surface change and linear depressions along the veins of his right forearm consistent with a groove sign. His fingers were held in a slight flexion contracture at the proximal interphalangeal joints (Figure, A).

First Page Preview View Large
First page PDF preview
First page PDF preview
×